A detailed history of Fiduciary Family Office, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fiduciary Family Office, LLC holds 6,926 shares of ABBV stock, worth $1.19 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
6,926
Previous 7,142 3.02%
Holding current value
$1.19 Million
Previous $1.22 Billion 11.65%
% of portfolio
0.45%
Previous 0.48%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$163.84 - $199.33 $35,389 - $43,055
-216 Reduced 3.02%
6,926 $1.37 Billion
Q2 2024

Aug 01, 2024

SELL
$154.79 - $180.76 $404,466 - $472,325
-2,613 Reduced 26.79%
7,142 $1.22 Billion
Q1 2024

May 07, 2024

BUY
$159.82 - $182.1 $48,105 - $54,812
301 Added 3.18%
9,755 $1.78 Billion
Q4 2023

May 07, 2024

BUY
$137.6 - $154.97 $1.3 Million - $1.47 Million
9,454 New
9,454 $1.47 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fiduciary Family Office, LLC Portfolio

Follow Fiduciary Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Family Office, LLC with notifications on news.